176 related articles for article (PubMed ID: 2891643)
1. Clinical value of calcitonin and carcinoembryonic antigen doubling times in medullary thyroid carcinoma.
Jackson CE; Norum RA; Talpos GB; Feldkamp CS; Tashjian AH
Henry Ford Hosp Med J; 1987; 35(2-3):120-1. PubMed ID: 2891643
[No Abstract] [Full Text] [Related]
2. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
4. Medullary thyroid cancer in a Wisconsin kindred with Sipple's syndrome: the use of provoked calcitonin testing.
Witte RS; Starling JR; Warner T; Davis TE
Wis Med J; 1982 Nov; 81(11):22-5. PubMed ID: 6130656
[No Abstract] [Full Text] [Related]
5. [Type II-B multiple endocrine neoplasms. A new sporadic case].
González-Atienza J; Pérez A; LupónJ ; Ribera E; Sobrino J; Lucaya J
Med Clin (Barc); 1984 Mar; 82(10):454-6. PubMed ID: 6143865
[No Abstract] [Full Text] [Related]
6. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
Surg Forum; 1979; 30():120-1. PubMed ID: 395674
[No Abstract] [Full Text] [Related]
7. [Preoperative cytologic diagnosis of medullary carcinoma of the thyroid].
Rabitti C; Fadda G; Minimo C; Coronetta F; Russo RM; Capelli A
Pathologica; 1989; 81(1072):171-7. PubMed ID: 2570396
[TBL] [Abstract][Full Text] [Related]
8. [Early detection of medullary thyroid carcinoma in multiple endocrine neoplasia type II].
Ezabella MC; Hayashida CY; Bisi H; Leite MO; Borelli A; Abelin NM; Cordeiro AC; Camargo RY; Toledo SP
Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(3):105-9. PubMed ID: 1983764
[TBL] [Abstract][Full Text] [Related]
9. Management of medullary thyroid carcinomas.
Hamoir M; Maisin JP; Warnier P; Ketelslegers JM; Rahier J
Acta Otorhinolaryngol Belg; 1987; 41(5):782-92. PubMed ID: 2899945
[No Abstract] [Full Text] [Related]
10. [Clinical signs in medullary cancers of the thyroid].
Delisle MJ; Gardet P; Laplanche A; Rougier P; Parmentier C
Bull Cancer; 1984; 71(3):165-71. PubMed ID: 6148974
[TBL] [Abstract][Full Text] [Related]
11. [Problems posed by medullary cancer of the thyroid].
Calmettes C
Rev Med Interne; 1984 Nov; 5(4):279-82. PubMed ID: 6151728
[No Abstract] [Full Text] [Related]
12. Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma.
González-Villalpando C; Madero A; Peña J; Ramírez R; Szymansky J; Ruiz JE; Zárate A
Arch Invest Med (Mex); 1985; 16(3):237-45. PubMed ID: 2870690
[No Abstract] [Full Text] [Related]
13. [Usefulness of calcitonin measurement for the diagnosis of medullary cancer of the thyroid in a family with multiple endocrine adenoma syndrome of type IIB].
Pumarino H; Riesco J; Michelsen H; Campino C; Cembal J; Generini G
Rev Med Chil; 1984 Jul; 112(7):675-80. PubMed ID: 6151224
[No Abstract] [Full Text] [Related]
14. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
[TBL] [Abstract][Full Text] [Related]
15. [A case of multiple endocrine neoplasia (MEN), type 2A. Immunohistochemical and ultrastructural study of medullary carcinoma of the thyroid].
Tabuse Y; Tabuse K; Kawaguchi T; Kodama E; Katsumi M; Hiraoka J; Ohno T
Nihon Geka Hokan; 1983 Sep; 52(5):736-43. PubMed ID: 6144294
[No Abstract] [Full Text] [Related]
16. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
Calmettes C; Moukhtar MS; Milhaud G
Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis.
Meijer JA; le Cessie S; van den Hout WB; Kievit J; Schoones JW; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2010 Apr; 72(4):534-42. PubMed ID: 19563448
[TBL] [Abstract][Full Text] [Related]
18. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type 2b with a good prognosis.
Kullberg BJ; Nieuwenhuijzen Kruseman AC
Arch Intern Med; 1987 Jun; 147(6):1125-7. PubMed ID: 2884942
[TBL] [Abstract][Full Text] [Related]
20. Advances in the diagnosis and treatment of medullary thyroid carcinoma.
Brunt LM; Wells SA
Surg Clin North Am; 1987 Apr; 67(2):263-79. PubMed ID: 2882613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
